Ludmila Okruhlicova

Dr. Ludmila Okruhlicova


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MBMonika Barteková
Monika Barteková
PŠPetra Šimončíková
Petra Šimončíková
MFMária Fogarassyová
Mária Fogarassyová
MIMonika Ivanová
Monika Ivanová
LOLudmila Okruhlicova
Ludmila Okruhlicova
MBMiroslav Barancik
Miroslav Barancik
Quercetin (QCT) is flavonoid that possesses various biological functions including anti-oxidative and radical-scavenging activities. Moreover, QCT exerts some preventive actions in treatment of cardiovascular diseases. The aim of present study was to explore effects of prolonged administration of QCT on changes induced by repeated application of doxorubicin (DOX) in rat hearts. We focused on the ultrastructure of myocardium, matrix metalloproteinases (MMPs), biometric parameters, and apoptosis induction. Our aim was also to examine effects of QCT on ischemic tolerance in hearts exposed to chronic effects of DOX, and to determine possible mechanisms underlying effects of QCT. Our results showed that QCT prevented several negative chronic effects of DOX: (I) reversed DOX-induced blood pressure increase; (II) mediated improvement of deleterious effects of DOX on ultrastructure of left ventricle; (III) prevented DOX-induced effects on tissue MMP-2 activation; and (iv) reversed effects of DOX on apoptosis induction and superoxide dismutase inhibition. Moreover, we showed that rat hearts exposed to effects of QCT were more resistant to ischemia/reperfusion injury. Effects of QCT on modulation of ischemic tolerance were linked to Akt kinase activation and connexin-43 up-regulation. Taken together, these results demonstrate that prolonged treatment with QCT prevented negative chronic effects of DOX on blood pressure, cellular damage, MMP-2 activation, and apoptosis induction. Moreover, QCT influenced myocardial responses to acute ischemic stress. These facts bring new insights into mechanisms of QCT action on rat hearts exposed to the chronic effects of DOX.

27 February 2013 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
RSRuzena Sotnikova
Ruzena Sotnikova
LOLudmila Okruhlicova
Ludmila Okruhlicova
JVJana Vlkovicova
Jana Vlkovicova
JNJana Navarova
Jana Navarova
BGBeata Gajdacova
Beata Gajdacova
PKPeter Krenek
Peter Krenek

15 September 2016 in Physiological Research
Verified
Journal Article
Closed access
Jan SlezakJan Slezak
Jan Slezak
BKB. Kura
B. Kura
KFK. Frimmel
K. Frimmel
MZM. Zálešák
M. Zálešák
TRTanya Ravingerová
Tanya Ravingerová
NTN. Tribulová
N. Tribulová
Excessive production of oxygen free radicals has been regarded as a causative common denominator of many pathological processes in the animal kingdom. Hydroxyl and nitrosyl radicals represent the major cause of the destruction of biomolecules either by a direct reaction or by triggering a chain reaction of free radicals. Scavenging of free radicals may act preventively or therapeutically. A number of substances that preferentially react with free radicals can serve as scavengers, thus increasing the internal capacity/activity of endogenous antioxidants and protecting cells and tissues against oxidative damage. Molecular hydrogen (H2) reacts with strong oxidants, such as hydroxyl and nitrosyl radicals, in the cells, that enables utilization of its potential for preventive and therapeutic applications. H2 rapidly diffuses into tissues and cells without affecting metabolic redox reactions and signaling reactive species. H2 reduces oxidative stress also by regulating gene expression, and functions as an anti-inflammatory and anti-apoptotic agent. There is a growing body of evidence based on the results of animal experiments and clinical observations that H2 may represent an effective antioxidant for the prevention of oxidative stress-related diseases. Application of molecular hydrogen in situations with excessive production of free radicals, in particular, hydroxyl and nitrosyl radicals is relatively simple and effective, therefore, it deserves special attention.

1 October 2017 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Closed access
Jan SlezakJan Slezak
Jan Slezak
BKBranislav Kura
Branislav Kura
PBPavel Babal
Pavel Babal
MBMiroslav Barancik
Miroslav Barancik
MFMiroslav Ferko
Miroslav Ferko
NTNarcis Tribulova
Narcis Tribulova
Irradiation of normal tissues leads to acute increase in reactive oxygen/nitrogen species that serve as intra- and inter-cellular signaling to alter cell and tissue function. In the case of chest irradiation, it can affect the heart, blood vessels, and lungs, with consequent tissue remodelation and adverse side effects and symptoms. This complex process is orchestrated by a large number of interacting molecular signals, including cytokines, chemokines, and growth factors. Inflammation, endothelial cell dysfunction, thrombogenesis, organ dysfunction, and ultimate failing of the heart occur as a pathological entity — “radiation-induced heart disease” (RIHD) that is major source of morbidity and mortality. The purpose of this review is to bring insights into the basic mechanisms of RIHD that may lead to the identification of targets for intervention in the radiotherapy side effect. Studies of authors also provide knowledge about how to select targeted drugs or biological molecules to modify the progression of radiation damage in the heart. New prospective studies are needed to validate that assessed factors and changes are useful as early markers of cardiac damage.

26 March 2012 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
PDF file
MIMonika Ivanová
Monika Ivanová
Ima DovinovaIma Dovinova
Ima Dovinova
LOLudmila Okruhlicova
Ludmila Okruhlicova
NTNarcisa Tribulová
Narcisa Tribulová
PŠPetra Šimončíková
Petra Šimončíková
MBMiroslav Barancik
Miroslav Barancik

1 January 2008 in Physiological Research
Verified
Journal Article
Closed access
NTNarcisa Tribulova
Narcisa Tribulova
VKV Knezl
V Knezl
LOLudmila Okruhlicova
Ludmila Okruhlicova
JSJ Slezák
J Slezák
Direct cell-to-cell communication in the heart is maintained via gap junction channels composed of proteins termed connexins. Connexin channels ensure molecular and electrical signals propagation and hence are crucial in myocardial synchronization and heart function. Disease-induced gap junctions remodeling and/or an impairment or even block of intercellular communication due to acute pathological conditions results in derangements of myocardial conduction and synchronization. This is critical in the development of both ventricular fibrillation, which is a major cause of sudden cardiac death and persistent atrial fibrillation, most common arrhythmia in clinical practice often resulting in stroke. Many studies suggest that alterations in topology (remodeling), expression, phosphorylation and particularly function of connexin channels due to age or disease are implicated in the development of these life-threatening arrhythmias. It seems therefore challenging to examine whether compounds that could prevent or attenuate gap junctions remodeling and connexin channels dysfunction can protect the heart against arrhythmias that cause sudden death in humans. This assumption is supported by very recent findings showing that an increase of gap junctional conductance by specific peptides can prevents atrial conduction slowing or re-entrant ventricular tachycardia in ischemic heart. Suppression of ischemia-induced dephosphorylation of connexin seems to be one of the mechanisms involved. Another approach for identifying novel treatments is based on the hypothesis that even non-antiarrhythmic drugs with antiarrhythmic ability can modulate gap junctional communication and hence attenuate arrhythmogenic substrates.